Differently from other dystroglycanopathies, GMPPB mutations can lead to a defect of neuromuscular transmission and congenital myasthenic syndrome due to altered glycosylation of the acetylcholine receptor subunits and other synaptic proteins [8,9,10]. Here, GMPPB is linked to congenital myasthenic syndrome.